Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases
PHILADELPHIA, PA — Carisma Therapeutics Inc. (Nasdaq: CARM) has broadened its collaboration with Moderna, Inc. (Nasdaq: MRNA) to focus on developing treatments for autoimmune diseases, marking a significant step in leveraging …
Carisma Therapeutics and Moderna Expand Partnership to Target Autoimmune Diseases Read More